ArticleGenes & genomics2026
Induction of TRIM22 during Clonorchis sinensis infection triggers intracellular ROS accumulation by suppressing the mTOR-mediated Nrf2 signaling pathway.
Article in Genes & genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundClonorchis sinensis infection triggers various hepatobiliary complications, including epithelial hyperplasia, chronic inflammation, periductal fibrosis, and cholangiocarcinogenesis through direct contact with worms and their excretory-secretory products (ESPs). We previously profiled differential transcriptome expression from three-dimensional cholangiocyte (H69 cells) spheroids constitutively and repetitively exposed to ESPs using microarrays and RNA-seq analysis. TRIM22 was upregulated in response to ESP exposure.
objectiveThis study aimed to elucidate the pathophysiological mechanism of TRIM22-mediated hepatobiliary abnormalities during C. sinensis infection.
methodsQuantitative reverse transcription polymerase chain reaction and immunoblot analyses were used to examine TRIM22 transcript and protein expression in ESP-treated H69 spheroids and 2D cultured cells. Transfection with TRIM22-specific small interfering RNA was performed to examine changes in intracellular reactive oxygen species levels and the expression of the redox-active transcription factor signaling pathway (mTOR/Nrf2) and its target genes. Liver tissues from C. sinensis-infected mice were stained with TRIM22 and Nrf2 polyclonal antibodies.
resultsTreatment of H69 cells with ESPs increased TRIM22 expression and AKT/mTOR signaling pathway activation. TRIM22 knockdown abolished ESP-induced mTOR activation but elevated Nrf2 nuclear translocation with subsequent increased expression of antioxidant and phase II detoxifying enzymes. The immunoreactivity of TRIM22 and Nrf2 showed distinctly different patterns in the liver of mouse infected with C. sinensis for three months.
conclusionTRIM22 upregulation during C. sinensis infection contributes to hepatobiliary abnormalities by disrupting redox homeostasis.
Indexed as
Identifiers
41118115What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.